Robert Lufkin MD: Extending Life with Rapamycin
from Health Longevity Secrets Hosted by Robert Lufkin MD
For this weeks episode we are going to look at a brief interview I recently did with James Strole about my upcoming presentation at the RAADFEST conference in October in San Diego. While the interview is entitled ‘Extending Life with Rapamycin’, I want to be clear that 1- the use of rapamycin is an off label use of an FDA approved prescription only drug, 2-rapamycin is a potentially dangerous drug that should only be used under the care of a physician with experience in this area, and 3- although extremely promising longevity results are present in animal models the longevity benefits of rapamycin in humans are still being determined. As you can tell I am looking forward all the great speakers at the RAADFEST conference this fall. https://raadfest.com/ ⭐ Enjoying the show? Please leave a 5-star review on Apple Podcasts — it takes 30 seconds and helps more people discover the science of health and longevity. Thank you! New episodes every other Tuesday. Subscribe so you don't miss one. Continue this conversation on Substack: https://robertlufkinmd.substack.com Lies I Taught In Medical School — Free sample chapter: https://www.robertlufkinmd.com/lies/ Web: https://www.robertlufkinmd.com YouTube: https://www.youtube.com/robertlufkinmd X: https://x.com/robertlufkinmd Instagram: https://www.instagram.com/robertlufkinmd/ TikTok: https://www.tiktok.com/@robertlufkin LinkedIn: https://www.linkedin.com/in/robertlufkinmd/
Embed this episode
What this episode covers
For this weeks episode we are going to look at a brief interview I recently did with James Strole about my upcoming presentation at the RAADFEST conference in October in San Diego. While the interview is entitled ‘Extending Life with Rapamycin’, I want to be clear that 1- the use of rapamycin is an off label use of an FDA approved prescription only drug, 2-rapamycin is a potentially dangerous drug that should only be used under the care of a physician with experience in this area, and 3...
No transcript yet.